Microbot Medical MBOT Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's cash provided by (used in) financing activity, including discontinued operation?
- Microbot Medical (MBOT) reported cash provided by (used in) financing activity, including discontinued operation of $2.51M in Q4 2025.
- How has Microbot Medical's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Microbot Medical's cash provided by (used in) financing activity, including discontinued operation decreased by 11.5% year-over-year, from $2.83M to $2.51M.
- What is the long-term trend for Microbot Medical's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2022 to 2025), Microbot Medical's cash provided by (used in) financing activity, including discontinued operation has grown at a 171.2% compound annual growth rate (CAGR), from $4.32M to $86.24M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.